Xianjin Yang, Jie Zeng, Changhong Jiang, Yi Zhang, & Xu Zhang. (2024). Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway. Permanyer.
Chicago Style (17th ed.) CitationXianjin Yang, Jie Zeng, Changhong Jiang, Yi Zhang, and Xu Zhang. Transcription Factor E2F7 Activates PKMYT1 to Partially Suppress Adriamycin Sensitivity in Gastric Cancer Through the MAPK Signaling Pathway. Permanyer, 2024.
MLA (9th ed.) CitationXianjin Yang, et al. Transcription Factor E2F7 Activates PKMYT1 to Partially Suppress Adriamycin Sensitivity in Gastric Cancer Through the MAPK Signaling Pathway. Permanyer, 2024.
Warning: These citations may not always be 100% accurate.